The global forensic genomics market was valued at USD 2.84 billion in 2025. The market is estimated at USD 3.09 billion in 2026 and is projected to reach USD 7.02 billion by 2036, at a CAGR of 8.6% during the forecast period 2026-2036. This report assesses DNA database growth, laboratory funding, genetic genealogy, Rapid DNA, forensic sequencing, interpretation software, the value chain, policy, cost per sample, competition, and growth opportunities.
The market covers products and services for human DNA analysis in criminal investigations, database entry, kinship testing, and the identification of disaster victims and missing people. Products range from sample collection, extraction, and quantification kits and autosomal, Y-chromosome, and X-chromosome short tandem repeat (STR) kits to genetic analyzers based on capillary electrophoresis, Rapid DNA systems and their cartridges, forensic next-generation sequencing (NGS) panels and sequencers, whole-genome sequencing and dense SNP genotyping for genealogy, automation, probabilistic genotyping and database software, and testing and genealogy services. Fingerprint, toxicology, and digital forensics, clinical and consumer genetic tests, and non-human uses such as food authenticity and environmental DNA are excluded, although wildlife forensics is reported under other applications.
Data from the Federal Bureau of Investigation (FBI) show that the National DNA Index System (NDIS) in the U.S. contains over 26.5 million offender profiles and over 1.48 million crime scene profiles, more than 200 laboratories take part in it, and the Combined DNA Index System (CODIS) has assisted in over 776,000 investigations, with CODIS software running at 132 sites across 65 countries. A running count reported by NBC News credits investigative genetic genealogy with helping to solve over 1,600 cases across North America. In July 2026, the FBI cleared Thermo Fisher Scientific's Applied Biosystems RapidINTEL Plus Cartridge on the RapidHIT ID System for qualifying crime scene samples, the first Rapid DNA workflow whose crime scene profiles can be searched in national CODIS after review by qualified staff.
Investigative genetic genealogy draws on consumer databases holding DNA from people who have never been convicted, which raises consent and privacy concerns; some genealogy databases have limited police access, several states regulate genealogy and familial searching, and arrestee collection and profile retention remain under legal debate in several countries. Public crime laboratories also struggle with backlogs, analyst recruitment, and budgets that change from year to year, and validation costs lead some to postpone NGS adoption. Interpreting mixed and low-template profiles from touched objects is difficult, even with probabilistic genotyping software, and new methods must stay compatible with the STR loci used in national databases and meet quality assurance and court admissibility requirements before routine use.
Forensic NGS, also called massively parallel sequencing, is a major opportunity, as a single run can cover STRs, identity and ancestry SNPs, phenotype markers, and mitochondrial DNA and performs better on degraded samples, mixtures, and missing persons cases. Rapid DNA for crime scene evidence lets investigators produce leads in hours instead of months, and disaster victim identification, missing persons programs, and new forensic laboratories in emerging economies widen the customer base. Key trends include the move from STR-only profiling to dense SNP and whole-genome analysis, the decentralization of testing to booking stations and the field, and wider use of automation, laboratory information management systems, and software-based interpretation.
By offering, the forensic genomics market is segmented into kits & consumables, instruments, software, and services. Kits & consumables are expected to hold the largest share in 2026, as extraction, quantification, and STR amplification kits are used in every DNA analysis, the flow of offender, arrestee, and crime scene samples into national databases keeps rising, and booking stations consume Rapid DNA cartridges on a recurring basis. Services are set to grow at the highest CAGR, as genetic genealogy is mostly carried out by specialist private laboratories, governments fund outsourcing to clear casework and sexual assault kit backlogs, and cold case, missing persons, and identification programs need external testing capacity. Software is also expected to grow strongly with wider use of probabilistic genotyping and laboratory information management systems.
By technology, the forensic genomics market is segmented into capillary electrophoresis, next-generation sequencing, Rapid DNA analysis, polymerase chain reaction (PCR), SNP microarrays, and other technologies. Capillary electrophoresis is expected to lead in 2026, since STR analysis on this platform is the standard for CODIS and other national databases as well as casework, crime laboratories worldwide own a large installed base of genetic analyzers, and the method is fully validated, accredited, and accepted in court. Next-generation sequencing is projected to record the highest CAGR, driven by whole-genome sequencing in genetic genealogy, better results on degraded and mixed samples and in missing persons work, and its ability to read ancestry, phenotype, and mitochondrial markers. Rapid DNA analysis is also expected to grow strongly as booking station use spreads and crime scene approvals follow.
By application, the forensic genomics market is segmented into criminal casework, DNA databasing, forensic genetic genealogy & cold case investigation, disaster victim identification & missing persons, paternity & kinship testing, and other applications. Criminal casework is expected to hold the largest share in 2026, given the volume of evidence from violent crimes, sexual assaults, and property crimes, the higher complexity and cost of casework compared with database samples, and public funding aimed at casework and sexual assault kit backlogs. Forensic genetic genealogy & cold case investigation is projected to grow at the highest CAGR, supported by its proven record in North America, dedicated state funding such as Florida's April 2026 partnership with Othram, the large pool of unsolved violent crimes and unidentified remains, and proposed federal support under the Carla Walker Act. DNA databasing remains a significant application as offender and arrestee collection continues to expand.
By end user, the forensic genomics market is segmented into government forensic laboratories, law enforcement agencies, private forensic laboratories, and academic & research institutes. Government forensic laboratories, covering public crime laboratories at every level of government as well as medical examiner offices, are expected to account for the largest share in 2026, as they handle most casework and database analysis, take part in NDIS, and receive public funding for equipment, consumables, and capacity. Law enforcement agencies are expected to grow at the highest CAGR, reflecting Rapid DNA use in booking stations, approval of Rapid DNA for qualifying crime scene samples, CEBR funding for Rapid DNA programs, and direct purchases of genealogy services by police departments and prosecutors. Private forensic laboratories are also set to grow strongly on the back of outsourcing and genealogy demand.
North America is expected to be the largest regional forensic genomics market in 2026, supported by the scale of CODIS, public grants for laboratory capacity and backlog work, and U.S. leadership in investigative genetic genealogy and Rapid DNA. Six of the eight profiled companies, among them Thermo Fisher Scientific, Promega, ANDE, and Othram, are based in the U.S. Europe holds a significant share, backed by large national databases such as the U.K. National DNA Database, cross-border exchange under the Prüm framework and Prüm II Regulation, established forensic institutes, and growing interest in NGS, although strict EU data protection rules shape how profiles are collected and kept and how genealogy can be used.
Asia-Pacific is projected to grow at the highest CAGR during the forecast period, as China, India, and Southeast Asian countries expand DNA databases and laboratory capacity, governments invest in public security and justice modernization, and Japan, South Korea, Australia, and Singapore adopt advanced forensic tools. China runs one of the world's largest forensic DNA databases, and India is building forensic infrastructure under justice reforms that give more weight to forensic evidence. In Latin America, laboratory investment, missing persons identification, and database programs in Brazil, Mexico, and Colombia support demand, while database development in the Gulf countries and capacity building in Africa drive growth in the Middle East & Africa.
The forensic genomics market is moderately consolidated in products, where a handful of life science firms provide the bulk of STR kits, analyzers, and Rapid DNA platforms, and fragmented in services, where private laboratories and genealogy providers compete across regions and applications. Suppliers compete on performance with low-template and degraded samples, mixture resolution, database compatibility, validation and accreditation support, turnaround time, and software. Leading players are developing Rapid DNA workflows for crime scene use, NGS and whole-genome sequencing solutions, interpretation software, and automated workflows, and are growing genealogy services through agency partnerships. Recent developments include the FBI approval of the RapidINTEL Plus Cartridge in July 2026, the Florida Attorney General's partnership with Othram in April 2026, and QIAGEN's forensic NGS portfolio built on its 2023 acquisition of Verogen.
Key companies profiled in the report include Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Netherlands), Promega Corporation (U.S.), ANDE Corporation (U.S.), Othram Inc. (U.S.), Parabon NanoLabs, Inc. (U.S.), Bode Technology Group, Inc. (U.S.), and Eurofins Scientific SE (Luxembourg).
The market covers products and services for human DNA analysis in criminal investigations, database entry, kinship testing, and the identification of disaster victims and missing people. Products range from sample collection, extraction, and quantification kits and autosomal, Y-chromosome, and X-chromosome short tandem repeat (STR) kits to genetic analyzers based on capillary electrophoresis, Rapid DNA systems and their cartridges, forensic next-generation sequencing (NGS) panels and sequencers, whole-genome sequencing and dense SNP genotyping for genealogy, automation, probabilistic genotyping and database software, and testing and genealogy services. Fingerprint, toxicology, and digital forensics, clinical and consumer genetic tests, and non-human uses such as food authenticity and environmental DNA are excluded, although wildlife forensics is reported under other applications.
Data from the Federal Bureau of Investigation (FBI) show that the National DNA Index System (NDIS) in the U.S. contains over 26.5 million offender profiles and over 1.48 million crime scene profiles, more than 200 laboratories take part in it, and the Combined DNA Index System (CODIS) has assisted in over 776,000 investigations, with CODIS software running at 132 sites across 65 countries. A running count reported by NBC News credits investigative genetic genealogy with helping to solve over 1,600 cases across North America. In July 2026, the FBI cleared Thermo Fisher Scientific's Applied Biosystems RapidINTEL Plus Cartridge on the RapidHIT ID System for qualifying crime scene samples, the first Rapid DNA workflow whose crime scene profiles can be searched in national CODIS after review by qualified staff.
Market Dynamics
Database expansion is the core driver of the forensic genomics market, because every new offender, arrestee, and crime scene profile requires collection, extraction, amplification, and analysis, and many U.S. states and other countries now collect DNA from arrestees and for a wider range of offenses. Larger databases produce more matches, which encourages further investment, while many emerging countries are setting up national databases, often on CODIS software, and the Prüm II Regulation adopted in 2024 strengthens DNA data exchange among EU member states. Public funding adds to demand, as the U.S. Bureau of Justice Assistance (BJA) opened its FY 2026 DNA Capacity Enhancement for Backlog Reduction (CEBR) grant program with a dedicated category for Rapid DNA in booking stations. Genealogy work on violent crimes, cold cases, and unidentified remains and the move of Rapid DNA from booking stations toward crime scene evidence are further growth drivers.Investigative genetic genealogy draws on consumer databases holding DNA from people who have never been convicted, which raises consent and privacy concerns; some genealogy databases have limited police access, several states regulate genealogy and familial searching, and arrestee collection and profile retention remain under legal debate in several countries. Public crime laboratories also struggle with backlogs, analyst recruitment, and budgets that change from year to year, and validation costs lead some to postpone NGS adoption. Interpreting mixed and low-template profiles from touched objects is difficult, even with probabilistic genotyping software, and new methods must stay compatible with the STR loci used in national databases and meet quality assurance and court admissibility requirements before routine use.
Forensic NGS, also called massively parallel sequencing, is a major opportunity, as a single run can cover STRs, identity and ancestry SNPs, phenotype markers, and mitochondrial DNA and performs better on degraded samples, mixtures, and missing persons cases. Rapid DNA for crime scene evidence lets investigators produce leads in hours instead of months, and disaster victim identification, missing persons programs, and new forensic laboratories in emerging economies widen the customer base. Key trends include the move from STR-only profiling to dense SNP and whole-genome analysis, the decentralization of testing to booking stations and the field, and wider use of automation, laboratory information management systems, and software-based interpretation.
Segment Analysis
The report analyzes the market by offering, technology, application, end user, and geography, helping stakeholders identify the most attractive areas for product development, service expansion, and investment.By offering, the forensic genomics market is segmented into kits & consumables, instruments, software, and services. Kits & consumables are expected to hold the largest share in 2026, as extraction, quantification, and STR amplification kits are used in every DNA analysis, the flow of offender, arrestee, and crime scene samples into national databases keeps rising, and booking stations consume Rapid DNA cartridges on a recurring basis. Services are set to grow at the highest CAGR, as genetic genealogy is mostly carried out by specialist private laboratories, governments fund outsourcing to clear casework and sexual assault kit backlogs, and cold case, missing persons, and identification programs need external testing capacity. Software is also expected to grow strongly with wider use of probabilistic genotyping and laboratory information management systems.
By technology, the forensic genomics market is segmented into capillary electrophoresis, next-generation sequencing, Rapid DNA analysis, polymerase chain reaction (PCR), SNP microarrays, and other technologies. Capillary electrophoresis is expected to lead in 2026, since STR analysis on this platform is the standard for CODIS and other national databases as well as casework, crime laboratories worldwide own a large installed base of genetic analyzers, and the method is fully validated, accredited, and accepted in court. Next-generation sequencing is projected to record the highest CAGR, driven by whole-genome sequencing in genetic genealogy, better results on degraded and mixed samples and in missing persons work, and its ability to read ancestry, phenotype, and mitochondrial markers. Rapid DNA analysis is also expected to grow strongly as booking station use spreads and crime scene approvals follow.
By application, the forensic genomics market is segmented into criminal casework, DNA databasing, forensic genetic genealogy & cold case investigation, disaster victim identification & missing persons, paternity & kinship testing, and other applications. Criminal casework is expected to hold the largest share in 2026, given the volume of evidence from violent crimes, sexual assaults, and property crimes, the higher complexity and cost of casework compared with database samples, and public funding aimed at casework and sexual assault kit backlogs. Forensic genetic genealogy & cold case investigation is projected to grow at the highest CAGR, supported by its proven record in North America, dedicated state funding such as Florida's April 2026 partnership with Othram, the large pool of unsolved violent crimes and unidentified remains, and proposed federal support under the Carla Walker Act. DNA databasing remains a significant application as offender and arrestee collection continues to expand.
By end user, the forensic genomics market is segmented into government forensic laboratories, law enforcement agencies, private forensic laboratories, and academic & research institutes. Government forensic laboratories, covering public crime laboratories at every level of government as well as medical examiner offices, are expected to account for the largest share in 2026, as they handle most casework and database analysis, take part in NDIS, and receive public funding for equipment, consumables, and capacity. Law enforcement agencies are expected to grow at the highest CAGR, reflecting Rapid DNA use in booking stations, approval of Rapid DNA for qualifying crime scene samples, CEBR funding for Rapid DNA programs, and direct purchases of genealogy services by police departments and prosecutors. Private forensic laboratories are also set to grow strongly on the back of outsourcing and genealogy demand.
Regional Analysis
The report covers North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, spanning 20 countries and four rest-of-region groups. The regional analysis considers national DNA database scale, public funding for crime laboratories, legal frameworks for DNA collection and genealogy, forensic laboratory capacity, and technology adoption.North America is expected to be the largest regional forensic genomics market in 2026, supported by the scale of CODIS, public grants for laboratory capacity and backlog work, and U.S. leadership in investigative genetic genealogy and Rapid DNA. Six of the eight profiled companies, among them Thermo Fisher Scientific, Promega, ANDE, and Othram, are based in the U.S. Europe holds a significant share, backed by large national databases such as the U.K. National DNA Database, cross-border exchange under the Prüm framework and Prüm II Regulation, established forensic institutes, and growing interest in NGS, although strict EU data protection rules shape how profiles are collected and kept and how genealogy can be used.
Asia-Pacific is projected to grow at the highest CAGR during the forecast period, as China, India, and Southeast Asian countries expand DNA databases and laboratory capacity, governments invest in public security and justice modernization, and Japan, South Korea, Australia, and Singapore adopt advanced forensic tools. China runs one of the world's largest forensic DNA databases, and India is building forensic infrastructure under justice reforms that give more weight to forensic evidence. In Latin America, laboratory investment, missing persons identification, and database programs in Brazil, Mexico, and Colombia support demand, while database development in the Gulf countries and capacity building in Africa drive growth in the Middle East & Africa.
Competitive Landscape
The report provides a detailed review of the competitive landscape, covering key growth strategies, competitive benchmarking, the competitive dashboard, and market share/rank analysis, together with company profiles that include business overviews, financial performance, forensic genomics and product/service portfolios, strategic developments, and SWOT analyses.The forensic genomics market is moderately consolidated in products, where a handful of life science firms provide the bulk of STR kits, analyzers, and Rapid DNA platforms, and fragmented in services, where private laboratories and genealogy providers compete across regions and applications. Suppliers compete on performance with low-template and degraded samples, mixture resolution, database compatibility, validation and accreditation support, turnaround time, and software. Leading players are developing Rapid DNA workflows for crime scene use, NGS and whole-genome sequencing solutions, interpretation software, and automated workflows, and are growing genealogy services through agency partnerships. Recent developments include the FBI approval of the RapidINTEL Plus Cartridge in July 2026, the Florida Attorney General's partnership with Othram in April 2026, and QIAGEN's forensic NGS portfolio built on its 2023 acquisition of Verogen.
Key companies profiled in the report include Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Netherlands), Promega Corporation (U.S.), ANDE Corporation (U.S.), Othram Inc. (U.S.), Parabon NanoLabs, Inc. (U.S.), Bode Technology Group, Inc. (U.S.), and Eurofins Scientific SE (Luxembourg).
How This Report Helps
- Provides reliable market size estimates and long-term forecasts for the global forensic genomics market.
- Explains how DNA database growth, crime laboratory funding, genetic genealogy, and Rapid DNA are shaping demand.
- Assesses the impact of privacy and legal concerns, laboratory staffing limits, and validation requirements on adoption.
- Identifies high-growth opportunities across offering, technology, application, end user, and region.
- Tracks forensic NGS, whole-genome sequencing for genealogy, Rapid DNA for crime scene samples, and interpretation software.
- Benchmarks leading product suppliers and service laboratories by portfolio, approvals, partnerships, and capabilities.
- Supports product planning, service expansion, partnering, and market entry decisions for suppliers, laboratories, agencies, and investors.
Key Questions Answered
- How big is the global forensic genomics market today, and how will it grow through 2036?
- How are national DNA databases and public funding programs driving demand for forensic products and services?
- What are the main drivers, restraints, opportunities, challenges, and trends shaping the market?
- How is investigative genetic genealogy changing cold case investigation, and what policy issues does it raise?
- What does the approval of Rapid DNA for crime scene samples mean for law enforcement and laboratories?
- Which offering, technology, application, and end user segments will grow the fastest?
- How quickly will forensic NGS replace or complement capillary electrophoresis?
- Which regions and countries offer the most attractive business opportunities?
- Who are the leading companies in the market, and how do they compete?
Table of Contents
1. Introduction
2. Research Methodology
4. Market Overview
5. Forensic Genomics Market, by Offering
6. Forensic Genomics Market, by Technology
7. Forensic Genomics Market, by Application
8. Forensic Genomics Market, by End User
9. Forensic Genomics Market, by Geography
10. Competitive Landscape
11. Company Profiles
12. Appendix
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
- Thermo Fisher Scientific Inc.
- QIAGEN N.V.
- Promega Corporation
- ANDE Corporation
- Othram Inc.
- Parabon NanoLabs, Inc.
- Bode Technology Group, Inc.
- Eurofins Scientific SE
